1
|
Furrie E, Macfarlane S, Cummings JH and
Macfarlane GT: Systemic antibodies towards mucosal bacteria in
ulcerative colitis and crohn's disease differentially activate the
innate immune response. Gut. 53:91–98. 2004. View Article : Google Scholar
|
2
|
Sakthivel KM and Guruvayoorappan C:
Protective effect of Acacia ferruginea against ulcerative colitis
via modulating inflammatory mediators, cytokine profile and NF-κB
signal transduction pathways. J Environ Pathol Toxicol Oncol.
33:83–98. 2014. View Article : Google Scholar
|
3
|
Ooi CJ and Sands BE: Treatment of
ulcerative colitis. Curr Opin Gastroenterol. 15:298–301. 1999.
View Article : Google Scholar
|
4
|
Chun J, Lee C, Hwang SW, Im JP and Kim JS:
Ursolic acid inhibits nuclear factor-κB signaling in intestinal
epithelial cells and macrophages and attenuates experimental
colitis in mice. Life Sci. 110:23–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Baricevic D, Sosa S, Della Loggia R,
Tubaro A, Simonovska B, Krasna A and Zupancic A: Topical
anti-inflammatory activity of Salvia officinalis L. leaves: The
relevance of ursolic acid. J Ethnopharmacol. 75:125–132. 2001.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Ku CM and Lin JY: Anti-inflammatory
effects of 27 selected terpenoid compounds tested through
modulating Th1/Th2 cytokine secretion profiles using murine primary
splenocytes. Food Chem. 141:1104–1113. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Wang J, Liu L, Qiu H, Zhang X, Guo W, Chen
W, Tian Y, Fu L, Shi D, Cheng J, et al: Ursolic acid simultaneously
targets multiple signaling pathways to suppress proliferation and
induce apoptosis in colon cancer cells. PLoS One. 8:e638722013.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Tang Q, Ji Q, Tang Y, Chen T, Pan G, Hu S,
Bao Y, Peng W and Yin P: Mitochondrial translocation of cofilin-1
promotes apoptosis of gastric cancer BGC-823 cells induced by
ursolic acid. Tumour Biol. 35:2451–2459. 2014. View Article : Google Scholar
|
9
|
Alqahtani A, Hamid K, Kam A, Wong KH,
Abdelhak Z, Razmovski-Naumovski V, Chan K, Li KM, Groundwater PW
and Li GQ: The pentacyclic triterpenoids in herbal medicines and
their pharmacological activities in diabetes and diabetic
complications. Curr Med Chem. 20:908–931. 2013.
|
10
|
D'Abrosca B, Fiorentino A, Monaco P and
Pacifico S: Radical-scavenging activities of new hydroxylated
ursane triterpenes from cv. Annurca apples. Chem Biodivers.
2:953–958. 2005. View Article : Google Scholar
|
11
|
Ali MS, Ibrahim SA, Jalil S and Choudhary
MI: Ursolic acid: A potent inhibitor of superoxides produced in the
cellular system. Phytother Res. 21:558–561. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
do Nascimento PG, Lemos TL, Bizerra AM,
Arriaga ÂM, Ferreira DA, Santiago GM, Braz-Filho R and Costa JG:
Antibacterial and antioxidant activities of ursolic acid and
derivatives. Molecules. 19:1317–1327. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Raphael TJ and Kuttan G: Effect of
naturally occurring triterpenoids glycyrrhizic acid, ursolic acid,
oleanolic acid and nomilin on the immune system. Phytomedicine.
10:483–489. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Malekinejad H, Shafie-Irannejad V,
Hobbenaghi R, Tabatabaie SH and Moshtaghion SM: Comparative
protective effect of hawthorn berry hydroalcoholic extract,
atorvastatin and mesalamine on experimentally induced colitis in
rats. J Med Food. 16:593–601. 2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Jang SE, Jeong JJ, Hyam SR, Han MJ and Kim
DH: Ursolic acid isolated from the seed of Cornus officinalis
ameliorates colitis in mice by inhibiting the binding of
lipopolysaccharide to Toll-like receptor 4 on macrophages. J Agric
Food Chem. 62:9711–9721. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wirtz S, Neufert C, Weigmann B and Neurath
MF: Chemically induced mouse models of intestinal infammation. Nat
Protoc. 2:541–546. 2007. View Article : Google Scholar
|
17
|
Hendrickson BA, Gokhale R and Cho JH:
Clinical aspects and pathophysiology of inflammatory bowel disease.
Clin Microbiol Rev. 15:79–94. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Aldini R, Micucci M, Cevenini M, Fato R,
Bergamini C, Nanni C, Cont M, Camborata C, Spinozzi S, Montagnani
M, et al: Antiinflammatory effect of phytosterols in experimental
murine colitis model: Prevention, induction, remission study. PLoS
One. 9:e1081122014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang L, Wang J, Wang Y, Fu Q, Lei YH, Nie
ZY, Qiu J and Bao TY: Protective effect of exogenous matrix
metalloproteinase-9 on chronic renal failure. Exp Ther Med.
7:329–334. 2014.PubMed/NCBI
|
20
|
Tahan G, Aytac E, Aytekin H, Gunduz F,
Dogusoy G, Aydin S, Tahan V and Uzun H: Vitamin E has a dual effect
of anti-inflammatory and antioxidant activities in acetic
acid-induced ulcerative colitis in rats. Can J Surg. 54:333–338.
2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhou YH, Yu JP, Liu YF, Teng XJ, Ming M,
Lv P, An P, Liu SQ and Yu HG: Effects of Ginkgo biloba extract on
infammatory mediators (SOD, MDA, TNF-alpha, NF-kappaBp65, IL-6) in
TNBS-induced colitis in rats. Mediators Inflamm. 5:926422006.
|
22
|
Tsai SJ and Yin MC: Antioxidative and
anti-inflammatory protection of oleanolic acid and ursolic acid in
PC12 cells. J Food Sci. 73:H174–H178. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Saraswati S, Agrawal SS and Alhaider AA:
Ursolic acid inhibits tumor angiogenesis and induces apoptosis
through mitochondrial-dependent pathway in Ehrlich ascites
carcinoma tumor. Chem Biol Interact. 206:153–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Lu J, Zheng YL, Wu DM, Luo L, Sun DX and
Shan Q: Ursolic acid ameliorates cognition deficits and attenuates
oxidative damage in the brain of senescent mice induced by
D-galactose. Biochem Pharmacol. 74:1078–1090. 2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Saravanan R and Pugalendi V: Impact of
ursolic acid on chronic ethanol-induced oxidative stress in the rat
heart. Pharmacol Rep. 58:41–47. 2006.PubMed/NCBI
|
26
|
Zhao J, Hong T, Dong M, Meng Y and Mu J:
Protective effect of myricetin in dextran sulphate sodium-induced
murine ulcerative colitis. Mol Med Rep. 7:565–570. 2013.
|
27
|
Farombi EO, Adedara IA, Awoyemi OV, Njoku
CR, Micah GO, Esogwa CU, Owumi SE and Olopade JO: Dietary
protocatechuic acid ameliorates dextran sulphate sodium-induced
ulcerative colitis and hepatotoxicity in rats. Food Funct.
7:913–921. 2016. View Article : Google Scholar
|
28
|
Lee JH, Lee B, Lee HS, Bae EA, Lee H, Ahn
YT, Lim KS, Huh CS and Kim DH: Lactobacillus suntoryeus inhibits
pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB
activation in experimental colitis. Int J Colorectal Dis.
24:231–237. 2009. View Article : Google Scholar
|
29
|
Zhang DK, Yu JJ, Li YM, We i LN, Yu Y,
Feng YH and Wang X: A Picrorhiza kurroa derivative, picroliv,
attenuates the development of dextran-sulfate-sodium-induced
colitis in mice. Mediators Inflamm. 2012:7516292012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Oishi M, Tokuhara K, Miki H, Tanaka Y,
Yamaki S, Kaibori M, Yoshizawa K, Yuri T, Yoshigai E, Nishizawa M,
et al: Temporal and spatial dependence of inflammatory biomarkers
and suppression by fluvastatin in dextran sodium sulfate-induced
rat colitis model. Dig Dis Sci. 59:2126–2135. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Zhang ZL, Fan HY, Yang MY, Zhang ZK and
Liu K: Therapeutic effect of a hydroxynaphthoquinone fraction on
dextran sulfate sodium-induced ulcerative colitis. World J
Gastroenterol. 20:15310–15318. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Fakhoury M, Coussa-Charley M, Al-Salami H,
Kahouli I and Prakash S: Use of artificial cell microcapsule
containing thalidomide for treating TNBS-induced Crohn's disease in
mice. Curr Drug Deliv. 11:146–153. 2014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Dharmani P, Leung P and Chadee K: Tumor
necrosis factor-α and Muc2 mucin play major roles in disease onset
and progression in dextran sodium sulphate-induced colitis. PLoS
One. 6:e250582011. View Article : Google Scholar
|
34
|
Lv R, Qiao W, Wu Z, Wang Y, Dai S, Liu Q
and Zheng X: Tumor necrosis factor alpha blocking agents as
treatment for ulcerative colitis intolerant or refractory to
conventional medical therapy: A meta-analysis. PLoS One.
9:e866922014. View Article : Google Scholar : PubMed/NCBI
|
35
|
Ma JQ, Ding J, Xiao ZH and Liu CM: Ursolic
acid ameliorates carbon tetrachloride-induced oxidative DNA damage
and inflammation in mouse kidney by inhibiting the STAT3 and NF-κB
activities. Int Immunopharmacol. 21:389–395. 2014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Ma JQ, Ding J, Zhang L and Liu CM: Ursolic
acid protects mouse liver against CCl4-induced oxidative stress and
inflammation by the MAPK/NF-κB pathway. Environ Toxicol Pharmacol.
37:975–983. 2014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zeng G, Chen J, Liang QH, You WH, Wu HJ
and Xiong XG: Ursolic acid inhibits T-cell activation through
modulating nuclear factor-κB signaling. Chin J Integr Med.
18:34–39. 2012. View Article : Google Scholar
|
38
|
Li L, Zhang X, Cui L, Wang L, Liu H, Ji H
and Du Y: Ursolic acid promotes the neuroprotection by activating
Nrf2 pathway after cerebral ischemia in mice. Brain Res.
1497:32–39. 2013. View Article : Google Scholar : PubMed/NCBI
|
39
|
Chen X, Wan Y, Zhou T, Li J and Wei Y:
Ursolic acid attenuates lipopolysaccharide-induced acute lung
injury in a mouse model. Immunotherapy. 5:39–47. 2013. View Article : Google Scholar
|
40
|
Gai L, Cai N, Wang L, Xu X and Kong X:
Ursolic acid induces apoptosis via Akt/NF-κB signaling suppression
in T24 human bladder cancer cells. Mol Med Rep. 7:1673–1677.
2013.PubMed/NCBI
|
41
|
Liu K, Guo L, Miao L, Bao W, Yang J, Li X,
Xi T and Zhao W: Ursolic acid inhibits epithelial-mesenchymal
transition by suppressing the expression of astrocyte-elevated
gene-1 in human nonsmall cell lung cancer A549 cells. Anticancer
Drugs. 24:494–503. 2013. View Article : Google Scholar : PubMed/NCBI
|